Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

each CAR T cell can recognize and lyse several tumor cells. Moreover, what supports the energy cost of synapse formation versus migration, two critical events that underlie serial killing are poorly ...

CAR T-cell therapy has significantly improved outcomes for B-ALL patients, but relapse still occurs in over 50% of cases, leaving many with limited treatment options. Ongoing research aims to ...

B-cell maturation antigen–directed chimeric antigen receptor (CAR) T-cell therapy demonstrated safety in patients with multiple myeloma (MM) and central nervous system (CNS) involvement ...

For example, Millipore supplies the QCM Quantitative Cell Migration assay that uses an 8-μM pore ... the fibroblasts migrate but they don't invade, because if they are able to invade, sooner ...